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In 1972 modern fibrin sealing was developed in Vienna. Since then fibrin has effectively been 
used as ‘biologic glue’ for a variety of applications including its use in orthopedic and trauma 
surgery. In this study, fibrin gels cross linked with genipin have been studied as a potential 
Annulus Fibrosus sealant material in case of intervertebral disc degeneration in the lower back. 
Since the material is aimed for in situ use, it must have mechanical properties similar to the 
native tissue for efficient function. For this purpose gel modulus were studied and compared to 
the native tissue stiffness modulus. Degradation rate and % contraction in these gels were studied 
to characterize its temporal properties. Gelling time of these gels was defined in this study using 
rheological methods.  The results from the gelation experiments using G' and G'' cross-over 
method were not in agreement with Winter-Chambon criterion for our gels. The results obtained 
by Winter-Chambon criteria suggest that these gels have an adequate Gelling time for a surgical 
procedure to take place. The stiffness study results show that these gels could be formulated with 
a modulus that would fall in the range of native annular tissue.  The degradation and contraction 
study results suggest that the gel is not readily susceptible to degradation and also the % 
contraction is negligible. 
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  Back pain is a common health issue and causes distress to a large number of patients with 
10% of those cases leading to chronic disability [1]. Pathologies of the intervertebral disc (IVD) 
in the lower spine are a common source of low back pain. The IVD is fibro cartilage structure 
that consists of an internal semi-fluid proteoglycan rich mass called the nucleus pulposus (NP) 
and an outer annulus fibrosus (AF) [2]. The mechanical role of the IVD is to transmit and 
distribute loads on the spine while allowing for flexibility in the spinal column. [2]. 
Degeneration of the intervertebral disc is usually attributed to structural failure combined 
with advanced signs of aging [3]. When fissures in the disc grow large enough to allow gross 
migration of the nucleus relative to the annulus, to the extent that disc periphery is affected, the 
disc is said to be herniated or prolapsed. This causes NP material to protrude into the AF. Most 
intervention procedures intended to diminish painful spinal conditions, including spinal fusion, 
total disc replacement and discectomy do not repair the disc or restore its original function and 
may limit mobility [4]. Current methods for AF repair are limited to sutures and modified sutures 
which do not compensate for loss of AF tissue or restore lost biomechanical properties[4]. An 
intact AF would prevent re-herniation of the NP. Combining NP replacement approaches with 
AF repair would serve to restore original function and prevent reherniation. 
Previous studies have shown that a genipin cross linked fibrin hydrogel satisfies the three 
basic requirements for a good AF sealant: the gel modulus matches the native annulus tissue, it 
supports the growth of disc cells and maintains adhesion to the tissue [5]. These gels are 
compatible with chondrocytes in vitro and inhibit inflammatory response when implanted in 
rats.[5]. However these studies fail to characterize the material’s gelling properties, degradation 
profile and in situ contraction upon gelling. In the present study we have used varying genipin 
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concentrations and cell adhesion proteins collagen and fibronectin are added to the formulation 
to see how they affect gel biomechanical properties. 
The primary objectives of the proposed study are: i) to characterize the viscoelastic 
properties of various fibrin-genipin gel formulations with respect to the native tissue properties 
using rheological analysis; ii) To investigate the gelation time of the gel and see the effect of 
temperature on the gelling process; and iii) to compare the contraction and degradation rates of 
various gel formulations. 
2.0 BACKGROUND 
2.1 Fibrinogen and Genipin  
Fibrinogen is a high molecular weight protein. It is a precursor of fibrin which is the 
basic element of a blood clot. Fibrinogen transforms into stable fibrin by means of thrombin and 
factor XIII which is activated by thrombin [6]. Fibrin monomers crosslink to produce a stable 
fibrin clot that can act as a ‘biologic glue’. It has long been approved for use as commercially 
available fibrin sealants which are used in cardiovascular operations and various types of 
surgeries especially in patients with haemostatic disorders and as an aid in adhesive sealing of 
wounds [7]. Fibrin sealants are typically found to be biocompatible without inducing excessive 
inflammation, foreign body reaction, tissue necrosis or extensive fibrosis. Although fibrin is a 
good sealant, its poor mechanical properties prevent us from considering its use for the proposed 
application as an AF sealant. However, crosslinking fibrin with a properly chosen crosslinker 
would enhance its mechanical properties to match that of the native AF tissue. Genipin has been 
chosen as a crosslinker for the fibrin gels in the present study. Genipin is an agent extracted from 
the gardenia fruit. Several studies have reported genipin to have much lower cytotoxicity over 
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gluteraldehyde which is a commonly used cross-linking agent [8] Genipin has been reported to 
bind with biological tissues and biopolymers such as chitosan, gelatin and fibrinogen [9]. To 
enhance cell viability, addition of extracellular proteins such as collagen and fibronectin was also 
experimented. Fibronectin is known to assist in formation of fibrin clot by increasing the 
adhesion between cells and by favoring their growth and migration [6]. 
2.2 Rheology  
Oscillatory shear techniques are commonly used to analyze the rheological behavior of 
viscoelastic materials. In this technique, relative contributions of viscous and elastic response of 
materials are measured to characterize the viscoelasticity. The timescale of these tests is defined 
by frequency of oscillation. A sinusoidal stress is applied to the sample over a range of 
frequencies and the resulting strain and phase angle is measured. 
The shear elastic or storage modulus    is defined as the amplitude ratio of the component of the 
stress (  ) in phase with the strain to the strain amplitude (  ). 
   =    cos(δ)/    
Where δ is the phase angle between stress and strain. Similarly shear viscous (or loss) modulus 
    is the amplitude ratio of the component of the stress in phase with the strain to the strain 
amplitude. 
   =    sin(δ)/    
For a perfect elastic material, the stress and the strain waveforms are in phase i.e δ =   ,    = 0 
and    has a finite value. Thus for a given value of   ,  
  gives a measure of the energy that is  




Similarly, for a perfect viscous material, the stress and the strain waveforms are completely out 
of phase i.e  
δ = 90°, G ′ = 0, and G ″ is finite. For such a situation, G ″ represents a measure of the energy that 
is dissipated during flow per cycle of oscillation for each value of   .  
However, δ value measured by a rheometer is initially termed as the ‘raw phase’. The raw phase 
is then corrected for the system inertia to obtain the ‘rheological’ phase angle δ. 
For viscoelastic materials like the gel that we are using, the phase angle is between    and    .  
The loss factor (tan δ) is the quotient of lost and stored deformation energy. 
tan δ = G ″/ G ′ 
The viscoelastic behavior of each real material consists of a viscous and elastic portion. The sum 
can be shown by a vector diagram when G ′ is plotted on the x-axis and G ″ on the y-axis.    is 
the  vector sum of the two and it depicts the gel stiffness properties. It can be represented by: 
 |  | =               . 
Dynamic shear measurements are used in the present study to characterize material’s stiffness 
properties as well as to yield information regarding the gel’s viscoelastic properties during its 
various stages of transformation form liquid state to a gel-like structure. It is done by: 
 Dynamic frequency Sweep test 
The samples are subjected to different frequency values at a constant stress and temperature and 
the storage (G') and loss (G'') modulus is recorded as a function of frequency. Whichever 
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modulus is dominant at a particular frequency will indicate whether the fully structured material 
appears to be elastic or viscous.  
 Dynamic Strain Sweep Test 
The samples are subjected to different shear stress values at a fixed frequency to determine the 
linear viscoelastic region of the material. As the stress increases, the corresponding shear strain 
also increases and the rheological response of the material is recorded. The complex modulus of 
the material (G*) is monitored as a function of strain values. The range in which G* values 
remain constant gives the linear viscoelastic region (the region where deformation is small 
enough for the modulus to be independent of deformation) for the material at given temperature 
and frequency. 
 Dynamic time sweep test 
A dynamic time sweep test is conducted to establish any variation in measurement in a given 
condition of temperature, frequency and stress (or strain). The variation of dynamic response (G' 
and G'') is attributed to changes in properties of the sample material. 
2.3 Gel Point (GP)  
Gel point(GP) is also termed as the Sol-Gel Transition Point and it is defined as the point 
where there is a sudden loss of flow due to abrupt change in viscoelastic properties from an 
initially liquid like state to a solid-like state [11]. A number of ways have been suggested to 
quantify the GP. A well-known method for determining the GP is by measuring the instant at 
which G ′ and G ″ cross each other in an oscillatory shear experiment with constant frequency 
[12] [14].  
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Another  method that has proved efficient for different types of polymers is based on the 
Winter-Chambon criteria wherein the GP is identified at the time instant at which G ′ and G ″ 
follow power law behavior i.e.          and         . [10][5][15][14][13] 
Here, n denotes the relaxation exponent and is related to material structure, ω is the angular 
frequency,    and    are proportionality constants. 
The loss tangent is given by tan (δ) =      
  
 
   
which implies that δ is independent of frequency at the GP but proportional to n. 
However, experiments on different types of polymers state that the crossover of G ′ and G 
“ coincides with the GP only in certain cases where the relaxation exponent(n) is 0.5 and the loss 
tangent(tan δ) is 1 [13][14][10]. 
The literature speaks of a gel as an infinite network polymer of chains. If one of the 
segments of a linear polymer in solution can crosslink with other segment on other chains, a gel 
will ultimately be formed. After each such intermolecular interaction, the weight average 
molecular weight (Mw) has increased so that the number of cross linking sites has increased. As 
the gel formation proceeds, more such units react and Mw increases until it becomes infinite [15]. 
This point is the GP. However, no experimental methods have been performed to measure GP by 
this method. 
Summarizing the previous research we can say that the GP can be identified in the following 
possible ways: 




 The intersection point of loss tangent(tan δ) at different frequencies or in other words, the 
point in a multifrequency test at which tan(δ) becomes independent of the frequency 
corresponds to the gel point of physically crosslinked systems [13]. 
 At the GP, the weight average molecular weight of the polymer solution is infinite i.e Mw 
→∞ [15]. 
3.0 MATERIALS AND METHODS 
Table 1: Table showing gel formulations tested for each study performed 
Gel Formulation 



















0:1      
0.125:1      
0.25:1      
0.5:1      
0.25:1+fibronectin      
0.25:1+collagen      
 
3.1 Gel stiffness testing  
3.1.1 Gel Fabrication 
Fibrinogen isolated from bovine plasma (Sigma-Aldrich) was dissolved in phosphate 
buffered saline (PBS) at concentrations of 200 and 250 mg/ml. The tube was vortexed and left in 
water bath to let the fibrinogen mix well. Thrombin isolated from bovine plasma (Sigma-
Aldrich) was dissolved in PBS at concentration of 100U/ml. To cross-link the fibrin gel genipin 
was used. Genipin(Wako) was dissolved in Dimethyl Sulfoxide (Fisher) at a concentration of 
400 mg/ml. Genipin quantities were different for different set of gels depending on what genipin-
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fibrin ratio was desired. In our experiment we used ratios of 0.25:1, 0.125:1 and 0.5:1. 
Fibronectin and collagen too were added in some of the experiments. In fibronectin-modified 
groups, fibronectin (Sigma-Aldrich) was added to the fibrinogen solution with a concentration of 
60μl/ml in the gel. In collagen-modified groups, collagen type I, isolated from rat tail tendon 
(BD Biosciences) was mixed with 10x PBS, dH2O, and NaOH and then added to the fibrinogen 
solution followed by mixing of thrombin and genipin solution into it to achieve a final 
concentration of 0.08 wt% or 0.8 mg/ml. 
While preparing the gel samples, molds with cylindrical wells of diameter 5mm and a 
depth of 2.5 mm were used. Fibrinogen of desired quantity was pipetted into the well. A mixture 
of genipin and thrombin was prepared and pipetted in the well containing fibrinogen while 
mixing the two solutions well. The method was repeated for all of the gels. Once prepared, the 
mold was kept in a closed chamber with some amount of PBS to create high humidity. The gel 
was then allowed to set for approximately 18 hrs which would let it crosslink properly. After 18 
hours, the fully cross-linked gels were carefully removed from the mold and placed in small 
tubes filled with a drop of PBS. 
3.1.2 Oscillatory Shear Tests to determine Gel stiffness 
 The gel formulations tested for stiffness (Error! Reference source not found.) were divided 
nto two groups of fibrin concentrations.1) 200mg/ml- 0.125:1, 0.25:1, 0.5:1 and 0.25:1+collagen 
2) 250mg/ml- 0.125:1 and 0.25:1. Gels used for stiffness testing were approximately 2.5mm 
thick with a diameter of 5mm. The tests were performed using a TA instruments AR 2000 
rheometer fitted with parallel plate geometry. It had flat plates of 8mm covered with sand paper. 
The testing temperature was maintained at 25°C for all tests by a temperature control system 
fitted to the rheometer. The gel was subjected to a controlled oscillation and its response to 
15 
 
varying frequencies and % strain values was recorded. The gel was allowed an equilibration time 
of 5 minutes followed by a dynamic frequency sweep at 1% strain from 0.032 to 32 Hz. The test 
concluded with a strain sweep at 0.5 Hz from 1 to 100% strain. The test protocol was adopted 
from Bron et al [16]. The elastic modulus (G') and viscous modulus (G'') and the phase angle (δ) 
were calculated at each point of the frequency and strain sweeps. ‘Rheology Advantage Data 
Analysis’ (TA instruments)’software was then used to plot the frequency and strain sweeps with 
respect to the complex modulus (G*). One gel each of 0.125:1 and 0.25:1 was subjected to repeat 
tests to determine variance associated with sample placement on the machine. To conduct these 
tests, after testing the gel once, it was taken out of the testing assembly, and tested again in the 
same way as a new gel is tested. 
3.2 Gel point determination 
3.2.1 Frequency and Strain Sweep Experiments 
 To determine the Gel Point (GP) of the hydrogel time sweep experiments need to be 
performed. However, prior to the time sweep, frequency and strain sweep experiments were 
carried out to decide the appropriate frequency and % strain values to be used for time sweep 
experiments. For this purpose, rheological measurements for 51µl of Fibrinogen dissolved at a 
concentration of 200mg/ml were performed at 37°C using a TA instruments AR2000 rheometer 
with 8mm parallel plates and the gap was set at 0.75mm. For the frequency sweep experiments, 
frequency was varied from 0.03 to 30 Hz at 1% strain while for the strain sweep experiments, 
%strain values from 0.01 to 100% were tested at 0.5 Hz frequency. No, thrombin, genipin or any 
agent that would cause the fibrinogen to cross-link was added since a solution with consistent 




3.2.2 Time Sweep Experiments 
The time sweep experiments were conducted using a Texas Instruments AR2000 
Rheometer fitted with parallel plate geometry with 8mm plates. The gel was surrounded by 
droplets of water and the working assembly was encapsulated in plastic tray held upside down to 
prevent the gel from dehydrating. Temperature of 37°C was maintained for all tests. Additional 
tests were conducted on 0:1 and 0.25:1 gels at 25°C and 4°C to see the effect of temperature on 
the gelling process. The gap was maintained at 0.75mm for all samples. Different gel 
formulations tested for GP studies are as listed in Table 1 and the sample volume for different gel 
formulations is shown in Table 2 
Table 2: Gel volumes used for different gel formulations tested in GP determination study. 
Sample Volume Gel Formulation 
 56µl 0:1 and 0.25:1+collagen 
56.8µl 0.25:1 and 0.25:1+fibronectin gels 
57.6µl 0.5:1 
 
The GP determination tests were conducted in two different ways: 
1. In the first set of experiments for GP determination a time sweep at constant shear 
frequency(1Hz) and %strain(3%) was performed for 30minutes to monitor the in situ 
gelation behavior of the hydrogel by looking at the elastic stored modulus(G') and 
viscous  loss modulus(G'') with time. 
2. Alternatively the gelation time was determined by employing the Winter-Chambon 
Criteria. Multi frequency tests were carried out in the frequency range of 0.5-5Hz (0.5, 2, 
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3.5 and 5 Hz) at 3% strain for 30 minutes and the gelation time was determined based on 
the value of tanδ at different frequencies. The testing protocol was adopted from Jiao et al 
[13]. 
 
3.3 Degradation Test 
Samples prepared for degradation test were similar to those for stiffness measurements. 
Swelling ratio and degradation studies were conducted on 0:1, 0.25:1, 0.5:1, 0.25:1+fibronectin 
and 0.25:1+collagen gels (see Table 1) and sample volumes were same as those for GP 
studies(Table 2). These gels were allowed to set at 37°C. After about 18 hours, gels were removed 
from their molds, weighed for Day 0 weights (Wi) and stored in 24-well culture plates at 37 °C 
with 1ml PBS added to each well. The well plate was wrapped in a parafilm to avoid water loss. 
At predefined time points, the gel was removed, blotted gently with filter paper to remove 
surface water and its swollen weight was taken (Ws). Lyophilization of each sample was carried 
out using a freeze drying method to obtain the dry weight (Wd). The swelling ratio was 
calculated using the formula (Ws –Wd) / Wd. The degradation percentage was calculated using 
the formula (Wd – Wi) / Wi   100% where Wi is the weight of the gel on day 0. 
3.4 Contraction Studies 
Contraction studies were carried out on 0:1, 0.25:1, 0.5:1, 0.25:1+fibronectin and 




Figure 1: Experimental set up for contraction test 
The set up of the experiment is shown in Figure 1.The solution of the gel was placed 
between two glass slides with .The ends of the glass slide were held with a paper clip to hold the 
assembly in place. Two filter paper soaked in water were placed on either side of the gel to 
prevent it from drying. The entire assembly was placed under the microscope with focus of the 
lens adjusted to give the best view of the gel underneath. The gel was kept under observation for 
60 minutes with images being captured at: 30sec, 1min, 5min, 10min, 20min, 30min and 
60min.(n=4 was tested for each gel formulation). Image J software was used to measure the area 
of the gel at each time point. 
4. 0 RESULTS 
4.1 Gel stiffness testing 
Rheological testing indicated that strain amplitude of these genipin cross-linked fibrin 
gels could be changed by varying the fibrin concentration and genipin:fibrin ratio to get desired 






Figure 2: Average Frequency sweep model showing a) dynamic shear modulus and b) phase angle for gels with 
varying fibrin concentrations and genipin to fibrin ratios compared to human AF. The data for human AF is 
adopted from an earlier study using the same experimental setup [5]. 
*-One way ANOVA on G* results showed that 0:1 and 0.125:1 gels had significantly different G* values from 
Human AF (P<0.05) 
Varying genipin:fibrin ratio also showed significant changes in gel stiffness 
properties.(Figure 2). The dynamic frequency and strain sweep results for all the above mentioned 

























































sweep results show that genipin cross-linked fibrin gels demonstrate an increased stiffness at 
higher frequencies. Stiffness test measurement for 0:1 gels and AF tissue were adopted from 
previously done tests. [5].  Figure 2a draws a comparison between the stiffness results from all the 
different gel formulations with the native AF tissue. Gels with higher fibrin concentration 
certainly make the gel stiffer. Gels made with 250mg/ml and 0.25:1 genipin:fibrin ratio were 
found to have stiffness values closest to that of native tissue stiffness properties. 
As far as the effect of genipin concentration is considered, it is seen that for 200mg/ml 
fibrin concentration, gels with 0.25:1 and 0.5:1 genipin: fibrin ratio have similar G* values even 
though one would expect the stiffness to be higher with higher genipin concentration. This is 
expected because if we look at G* values in 0:1, 0.125:1 and 0.25:1 gels, it increases as the 
genipin concentration is increased (Figure 2a). Also for 250mg/ml fibrin concentration, the G* 
value is increased when genipin:fibrin ratio changes from 0.125:1 to 0.25:1 (Figure 2a). Collagen 
increases the gel stiffness to some extent but it does not make a very significant change from 
0.25:1 or 0.5:1 gels. Figure 2b shows the phase angle value at 1Hz for various gel formulations. 
For all the formulations the phase angle value is below 10 degrees which means the behavior is 
more elastic than viscous. Native tissue has a phase value of 18 degrees at 1Hz which is much 
closer to 0 degrees than 90 degrees. So it can be concluded that the native tissue too exhibits 
more elastic properties than viscous. 
It was seen from stiffness results that these gels have a very high batch to batch 
variability (ranging from 10% to 40% for different gel formulations). To evaluate the variability 
associated with specimen placement and device handling techniques, a few repeat tests were 





Figure 3: Results from repeat tests for two gels each of 0.125:1 and 0.25:1 to find the source of variance in results 
The data of the repeat tests show a maximum variance of 4% which is negligible compared to 
maximum variance in the original data set that is close to 40%. This suggests that the high 
variability in results is not an outcome of inconsistent sample handling or device operation and 
that it comes from other sources such as batch variation and gel mixing.  
4.2 Gel Point determination 
The working frequency was selected based on the raw phase of the data. As described in 
the background section, raw phase is essentially the measured phase difference between the 
sinusoidal torque and displacement in an oscillatory experiment prior to correction for system 
inertia which gives phase angle δ. The frequency at which, the phase angle between the applied 
torque and the resulting displacement is zero would be equivalent to an elastic solid. However, 
these viscoelastic gels contain viscous components that dissipate energy. Hence we would 




Figure 4: Frequency Sweep experiment results from 4 different samples of 200mg/ml Fibrinogen solution. The blue 
colored sinusoid indicates applied stress and the red is the resulting strain on arbitrary scales with data taken from 
the circled areas in the frequency sweep. 
 





Figure 4 shows the phase angle at three different frequency points. At lower frequencies, 
the phase angle is not very high but the response is noisy (Figure 4a). As the frequency increases, 
the response gets clearer and in the range of 0.7-1.2 Hz frequency, the noise as well as the phase 
angle is at a minimum (Figure 4b). As the frequency increases beyond that range, the phase angle 
starts to increase and at much higher frequencies it is almost 90° out of phase (Figure 4c). Table 3 
gives precise information about the frequency in the range of 0.7-1.2 Hz for all four gels. A 

































 Frequency(Hz)   
 Point 1 Point 2 Point3 




Gel 1 0.7536 0.9487 1.194 
0.9487 1 Hz 
Gel 2 0.7536 0.9487 1.194 
Gel 3 0.7536 0.9487 1.194 









median value for the three points in the selected range was calculated and an average of those 
median values was used to select 1Hz as the frequency for the gelation test time sweep.  
A similar strain sweep test was used to determine the % strain value strain value for 
gelation tests. Oscillatory strain sweep experiments were conducted and the phase angle was 
observed at different %strain values. It was observed that in the range of 2.1-3.5% strain, the 
phase angle and the signal noise were at a minimum (Figure 5c). % strain values falling below that 
range produced noisy responses (Figure 5b) while % strain values beyond that range had very high 
phase angle (Figure 5c) which is not desirable. 
 
Figure 5:Strain Sweep experiment results from 4 different samples of 200mg/ml Fibrinogen solution. The blue 
colored sinusoid indicates applied stress and the red is the resulting strain at the marked areas. 












































Figure 6: Dynamics of elastic, G' and viscous G'' moduli and loss tangent tanδ (inset graph) at1Hz for (a) 
Genipin:fibrinogen=0:1 and (b) genipin:fibrinogen=0.25:1. The gelation time is determined as the time at which G' 
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Table 4 gives the % strain values for the four samples in the range of 2.1-3.5%. The median of 
three points in each sample was calculated and the average of those median points was used to 
select 3% strain as the value to be used for gelation testing. 
Table 5: Values of G' and G'' at different time points starting from when the test begins to the point when G' and G'' 
cross each other for (a) 0:1 Gels and (b) 0.25:1 Gels. These values were recorded only for a few samples and do not 
necessarily represent the complete data set. Crossover values for all the samples could not recorded since it 
occurred too early.  
Table 5a-0:1 Gels 
Time(s) G’(Pa) G”(Pa) 
6.5620 19.49 26.16 
13.187 29.28 23.92 
19.734 32.07 24.09 
 
To define the GP, time sweep experiments were conducted and the crossover of G' and 
G'' was monitored for genipin:fibrinogen ratios of 0:1 and 0.25:1(Figure 6a and Figure 6b 
respectively). At the beginning, G' is lower than G'' which was expected since the samples were 
still in liquid state and thus viscous properties dominated. As the solution began to turn into a 
gel-like state due to formation of cross-links, both moduli increased. However, the rate of 
increase of G' was higher than G'' since the elastic properties began to dominate. This difference 
in rates leads to G' and G'' crossover. The time required to achieve this crossover is the gelation 
time. As seen in Figure 6a, the crossover occurs quite early in time. Table 5 gives precise G' and G'' 
 % Strain    
 Point 1 Point 2 Point3 Median 
Average Selected 
%Strain 




Gel 2 2.1746 2.7419 3.5103 2.7419 
Gel 3 2.0856 2.7407 3.3307 2.7407 
Gel 4 2.1017 2.6056 3.3059 2.6056 
Table 5b-0.25:1 gels 
Time(s) G’(Pa) G”(Pa) 
6.5620  6.861 10.04 
13.187 7.906 0.4847 




values so that time for the crossover can be observed. It is seen that for 0:1 as well as 0.25:1 gels, 
the crossover occurs somewhere between 6.5-13 sec from the start of the test (Table 5). The 
sample loading time was recorded to be approximately 25 sec. Add to it the time recorded on the 
graph, the total gelling time would be around 31.5-38sec. 
As mentioned earlier, the gelation time was also evaluated from the plots of loss tangent 
(tan δ) versus time at multiple frequencies to validate the results from G' and G'' crossover 
experiments since the literature states that the cross-over method of determining the GP is valid 
only for some network polymers and wrong for others [14]. It was studied that the method works 
only for polymers that have a relaxation exponent n=0.5 and tanδ=1. ‘n’ was evaluated for our 
gels by an inbuilt model in the Data Analysis software and it was found to be greater than 1 for 
all our gels which explains the reason for not being able to get a practically useful value of GP 
by the cross-over method. Another method was based on using the Winter-Chambon criterion 
which works on the hypothesis that tan (δ) is frequency independent at the GP.  shows a 
representation of the behavior of loss tangent tan (δ) versus time at different constant frequencies 
for pure fibrin as well as 0.25:1, 0.5:1, 0.25:1+fibronectin and 0.25:1+collagen gels. One can see 
that tan (δ) lines for different frequencies coincide at the gel point. Beyond this point, tan (δ) 
decreases more gradually as a result of formation of elastic gel. It is observed that pure fibrin 
gels have the lowest gel time.  
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Figure 7: A summary of loss tangent tan(δ) versus time 
for a) 0:1 gels b) 0.25:1 gels c) 0.5:1 gels d) 
0.25:1+fibronectin and e) 0.25:1+collagen gels at 
different frequencies:0.5Hz, 2Hz, 3.5hz and 5Hz.It 
should be noted that these figures are only a rough 
representation of the complete set. The complete figure 
set is shown in Figure 22 through Figure 26 
 
 

























































































 However the GP does not remain constant even for the same gel formulation when repeated tests 
are done. Figure 22 through Figure 26 gives a detail description of the variability by listing the plots 
from repeat tests for each gel formulation. Four gels for each gel formulation were tested. Based 





Table 6: Gelling time ±SD for different gel formulations: 0:1, 0.25:1, 0.5:1, 0.25:1+fibronectin and 
































Gel Formulation Gelling Time(secs) 
0:1 201.7 52.5 
0.25:1 860.7 60.7 
0.5:1 685.7 100.3 
0.25:1+fibronectin 741.7 130.2 
0.25:1+collagen 905.5 50.9 
 
 
Figure 8: Bar graph representation of gelling time for each gel formulation 
based on the data in Figure 22 to Figure 26. * One way ANOVA results 










Figure 9: Tan (δ) results for 0.25:1gels at multiple frequencies for a) 37 C b) 25 C and c) 4 C 
In order to evaluate the effect of temperature on gelling time, 0.25:1 gels were tested for 
37°C, 25°C and 4°C. Figure 9 shows the gelling time for each temperature. For the gels at 37°C 
tan (δ) shows a rapid drop as well as starts to converge close to  800s (Figure 9a). For the gels at 
25°C tan (δ) convergence begins around 1200sec (Figure 9b) which can be defined as the GP. 
However for the 4°C, no convergence or dropping of tan (δ) values is observed within the time 





































































range of the test (Figure 9c) which suggests that it takes more than 30mins for the GP to occur in 
this case. 
  
Figure 10: Tan (δ) values plotted against time for 0.25:1 gels at a) single frequency of 1Hz and b) multiple 
frequencies: 0.5Hz, 2Hz, 3.5Hz and 5Hz. 
Pure fibrin gels clearly have the lowest gelling time while 0.25:1 and the gels with collagen 
added take the maximum time to gel (Table 6). Having performed both methods for GP 
determination, a comparison between the two was drawn. Figure 10 shows tan (δ) values for 
single frequency (Figure 10a) as well as multi-frequency test (Figure 10b) for 0.25:1 gels. It is seen 
that tan (δ) value begins to drop around the same time in both cases and falls within the range 
defined for the gel in  
Figure 27 to Figure 31 show divergence in viscosity at the sol-gel transition. The complex 
viscosity of pure fibrin gels was compared to the same gel with addition of genipin at different 
concentrations and by adding collagen and fibronectin to it. The point at which viscosity value 
stabilizes would ideally be where the gel has fully crosslinked i.e it is completely gel-like. The 
results show that viscosity stabilizes as early as 500sec for pure fibrin gels while the stabilization 
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for other gel formulations in some cases occurs close to the end of 30 minute test while for some 
cases it doesn’t occur within the time frame of the test. 
 4.3 Degradation Study 
 
Figure 11: Equilibrium swelling ratio of 0:1, 0.25:1, 0.5:1, 0.25:1+fibronectin and 0.25:1+collagen gels in PBS at 
37°C. 
Figure 11 shows the swelling ratio measured for all the gel formulations. Fibrin gels swelled up 
infinitely after day 4. As a result of that they also tend to degrade completely at day 7 and that is 
why they are not shown beyond that point in Figure 11. Swelling ratio of all other gel formulations 
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Figure 12: % water content representing degradation of 0:1, 0.25:1, 0.5:1, 0.25:1+fibronectin and 0.25:1+collagen 
gels in PBS at 37°C measured at day1,5,7,10,14 and 21.The value of fibrin gels approaching 1 for day 7 indicated 
that the specimen had completely degraded and was all water. 
Figure 12 shows the degradation profile or the water content of the tested gel formulations over 21 
days. Apart from pure fibrin gels, other gel formulations did not show significant difference in 
their degradation profile over the 21 day time point. The water content of all gel formulations 
except pure fibrin gels that degraded completely by day7 did not show a significant change over 
a course of 21 days. A negligible change in swelling ratio values for all gel formulations except 
pure fibrin gels also indicate that the gels do not absorb much water overtime and hence takes 
longer to degrade. A two-way ANOVA was completed for this data, and there was significance 
between some data points, but these were not consistent across all time points for any one data 

























0.25:1 + Fibronectin 
0.25:1 + Collagen 
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4.4 Gel Contraction 
 
Figure 13: % contraction in 0:1, 0.25:1, 0.5:1, 0.25:1+fibronectin, 0.25:1+collagen measured over a time range of 
60minutes. 
Gel contraction studies were done to evaluate the percentage contraction of the gel. Figure 
13 shows the %contraction for each gel formulation. Based on that data, Table 7 was formulated 
summarizing percentage contraction in each gel.  
Table 7: % contraction calculated for each gel formulation based on Fig10. 
Gel Formulation %contraction 
0:1 5 1.82 
0.25:1 2 4.16 
0.5:1 10 2.06 
0.25:1+fibronectin 3 0.73 
0.25:1+collagen 6 1.38 
 
0.25:1 gel contracts the least with contraction close to 2% while the gel with 0.5:1 contracts the 
































Average Contraction 0:1 
0.25:1 
0.5:1 
0.25 + Fibronectin 
0.25:1 + Collagen 
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Fibrin gels have % contraction similar to that of the 0.25:1+collagen gels while 
0.25:1+fibronectin have a contraction pattern similar to 0.25:1 gels. A Two way ANOVA was 
completed for this result and it was seen that there was no significant difference between the 
contraction of all gel formulations. Also, there was no significant contraction seen for any of the 
formulations. (P>0.05) 
The method used for measuring the area of the image to calculate the contraction, was 
prone to human error. Hence repeat tests were done to quantify the maximum possible error in 
measurement. Error in the range of +0.1-4% was observed. Therefore, the error % must be 




5.0 COMPLETE EXPERIMENTAL RESULTS: 
 
(a)                                                           (b) 
 
(c)                               (d) 
 
 
Figure 14: Gels with fibrin concentration 200mg/ml and genipin:fibrin ratio 0.125:1 tested at 25°C for Dynamic 
frequency sweep at 1%strain for a) |G*| and b) δ(degrees)  and dynamic strain sweep at 0.5Hz frequency for c) |G*| 
and d)δ(degrees) 
 















































































































































(a)                                 (b) 
 
(c)                                  (d) 
 
Figure 15: Gels with fibrin concentration 200mg/ml and genipin:fibrin ratio 0.25:1 tested at 25°C for Dynamic 
frequency sweep at 1%strain for a) |G*| and b) δ(degrees)  and dynamic strain sweep at 0.5Hz frequency for c) |G*| 
and d)δ(degrees) 
  


















































































































































(a)                                            (b) 
 
(c)                                                  (d) 
Figure 16: Gels with fibrin concentration 200mg/ml and genipin:fibrin ratio 0.5:1 tested at 25°C for Dynamic 
frequency sweep at 1%strain for a) |G*| and b) δ(degrees)  and dynamic strain sweep at 0.5Hz frequency for c) |G*| 
and d)δ(degrees) 
 




































































































































(a)                                 (b) 
 
(c)                                       (d) 
 
Figure 17: Gels with fibrin concentration 200mg/ml and genipin:fibrin ratio 0.25:1+collagen tested at 25°C for 
Dynamic frequency sweep at 1%strain for a) |G*| and b) δ(degrees)  and dynamic strain sweep at 0.5Hz frequency 






































































































































(a)                            (b) 
 
(c)                                   (d) 
Figure 18: Gels with fibrin concentration 250mg/ml and genipin:fibrin ratio 0.125:1 tested at 25°C for Dynamic 
frequency sweep at 1%strain for a) |G*| and b) δ(degrees)  and dynamic strain sweep at 0.5Hz frequency for c) |G*| 
and d)δ(degrees) 
 


























































































































(a)                               (b) 
 
(c)           (d) 
Figure 19: Gels with fibrin concentration 250mg/ml and genipin:fibrin ratio 0.25:1 at 25°C for Dynamic frequency 
sweep at 1%strain for a) |G*| and b) δ(degrees)  and dynamic strain sweep at 0.5Hz frequency for c) |G*| and 
d)δ(degrees) 
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   (e)           (f) 
    
   (g)                        (h) 
Figure 20: Time sweep test results for GP determination in 0:1 gels for 1Hz frequency and 3% strain at 37°C for 
n=4 a), c), e), g) G',G'' vs time. b), d), f), h) tan (δ) vs time. The crossover point occurs very early in time so it 
cannot be captured on the graph  
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   (e)      (f) 
     
   (g)           (h) 
Figure 21: Time sweep test results for GP determination in 0.25:1 gels for 1Hz frequency and 3% strain at 37°C for 
n=4 a), c), e), g) G',G'' vs time. b), d), f), h) tan (δ) vs time. The crossover point occurs very early in time so it 
cannot be captured on the graph  
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(a)                     (b) 
 
(c)          (d) 
Figure 22: Multifrequency Time sweep test results for GP determination in 0:1 gels for 3% strain and frequency of 
0.5,2,3.5 and 5 Hz at 37 C for n=4. The point marked is in the figure is where tanδ for different frequencies 
converge or the GP.  




















Multifrequency test (0:1 Gel1)




















Multifrequency test (0:1 Gel2)




















Multifrequency test (0:1 Gel3)
























(a)          (b) 
 
(c)        (d) 
Figure 23: Multifrequency Time sweep test results for GP determination in 0.25:1 gels for 3% strain and frequency 
of 0.5,2,3.5 and 5 Hz at 37 C for n=4. The point marked is in the figure is where tanδ for different frequencies 
converge or the GP.  























































































(a)                   (b) 
 
(c)             (d) 
Figure 24: Multifrequency Time sweep test results for GP determination in 0.5:1 gels for 3% strain and frequency 
of 0.5,2,3.5 and 5 Hz at 37 C for n=4. The point marked is in the figure is where tanδ for different frequencies 
converge or the GP. 























































































(a)           (b) 
 
(c)         (d) 
Figure 25:  Multi-frequency Time sweep test results for GP determination in 0.25:1+fibronectin gels for 3% strain 
and frequency of 0.5,2,3.5 and 5 Hz at 37 C for n=4. The point marked is in the figure is where tanδ for different 
frequencies converge or the GP  























































































(a)          (b) 
 
(b)          (d) 
Figure 26: Multifrequency Time sweep test results for GP determination in 0.25:1+collagen gels for 3% strain and 
frequency of 0.5,2,3.5 and 5 Hz at 37 C for n=4. The point marked is in the figure is where tanδ for different 
frequencies converge or the GP 
  









































Multifrequency test (0.25:1+collagen Gel2)














































Figure 27: Dynamic viscosity measurement for 0:1 gels at multiple frequencies: 0.5,2, 3.5 and 5Hz for n=4. The 
marked value represents the point beyond which viscosity value reaches steady state 
  






























































































Figure 28: Dynamic viscosity measurement for 0.25:1 gels at multiple frequencies: 0.5,2, 3.5 and 5 Hz for n=4. The 
marked value represents the point beyond which viscosity value reaches steady state  































































































Figure 29: Dynamic viscosity measurement for 0.5:1 gels at multiple frequencies: 0.5,2, 3.5 and 5 Hz for n=4. The 
marked value represents the point beyond which viscosity value reaches steady state  






























































































Figure 30: Dynamic viscosity measurement for 0.25:1+fibronectin gels at multiple frequencies: 0.5,2, 3.5 and 5 Hz 
for n=4. The marked value represents the point beyond which viscosity value reaches steady state  































































































Figure 31: Dynamic viscosity measurement for 0.25:1+collagen gels at multiple frequencies: 0.5,2, 3.5 and 5 Hz 
for n=4. The marked value represents the point beyond which viscosity value reaches steady state 





























































































Figure 32: % contraction in 0:1 gels, 0.5:1 gels, 0.25:1 gels and 0.25:1+fibronectin gels and 0.25:1+collagen gels 

















































































 As described in previous sections, the current study was divided into 4 different parts 
with each section testing a unique property of the genipin cross-linked fibrin gels. Shear tests 
characterized gel stiffness properties, GP determination tests defined the gelling time. The 
degradation test quantified the temporal stability of the gel’s hydration and dimensions in high 
humidity environment. All of these properties are essential in describing genipin crosslinked 
fibrin gel’s potential success for its intended use as an injectable material for AF repair. Gels 
with varying genipin concentrations were used for this purpose and the effect of addition of 
collagen and fibronectin was also observed. Our shear test results showed that genipin was 
required to achieve a modulus close to the native tissue. Also, these gels can be tuned to have a 
modulus suitable to match native human AF tissues by varying genipin:fibrin ratio and fibrin 
concentrations. Results from the gelation test demonstrated that fibrin reached the gelation point 
in a few minutes after it was loaded onto the test machine but that addition of genipin increased 
the gelling time to values considered more useful for mixing and injecting into a patient but still 
short enough so that it would be very solid by the time a surgical procedure was completed. It 
was also seen that gelling time shows a very evident temperature dependency occurring more 
rapidly at body temperature than room temperature. Another important conclusion was that the 
G' and G'' crossover method of GP determination does not hold true for our gels. Rather the 
Winter-Chambon criterion was more useful for our genipin crosslinked fibrin gels since it gives  
GP values which could be validated by the observations while handling the gel. The degradation 
test results lead us to believe that our gels do not completely degrade over a period of 21 days 
except for the fibrin gels which degrdaded completely on the 7
th 
day. Lastly the contraction 
studies suggest that there is minimum contraction taking place as the gel turns from a liquid to a 
fully crosslinked gel. 
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The stiffness results from rheological testing indicate that a desired value of modulus can 
be achieved by varying the concentrations based on the specific purpose. However, it is essential 
to assess these behaviors across a broad range of loading conditions. Increasing the fibrin 
concentrations causes a linear increase in modulus of the gel. However, increasing the genipin 
concentration does not lead to a linear increase in modulus although it does increase the modulus 
in some cases. As discussed earlier, these tests had high variability. It was seen that the 
variability arises usually when a new batch of gels was made. All gels made in a single batch 
showed similar results. Although this variability is noted in all gel formulations, it was the most 
prominent for 0.125:1 gels (Figure 14). A variety of reasons could be assumed for this source of 
variation.  Pipette mixing was used as the standard technique which is subject to high degree of 
variability. Fibrin being a biological material is also susceptible to variations. Genipin solution 
once made can ideally be used for 14 days. However, it might make a difference to use freshly 
made genipin as opposed to the genipin that has been stored for a week. To overcome these 
sources of errors the following could be considered in future: using syringe mixing to ensure 
proper mixing and delivery of equal amounts each time and to use freshly made genipin for 
every new batch of gels. 
 For the design of injectable sealant material, an important property is to have a well 
defined solidification rate or the gelation time. The gelation time needs to be balanced to be short 
enough to shorten the waiting time for the patient and prevent extrusion of the hydrogel from the 
injection site but on the other hand it should be of sufficient duration to allow for a proper 
surgical procedure to take place. Despite the relevance of this property that is related to the 
structure and composition of the gel formulations as well as their processing conditions not much 
work has been done in this area. A majority of previous studies to quantify the GP for gels utilize 
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the G' and G'' cross-over method.[17][10][18]. However some work suggests that G' and G'' 
crossover method is not a standard method to characterize the GP for all 
polymers[14][5][15][13]. It is found that crossover of G' and G'' coincides with the GP only in 
certain cases, where the relaxation exponent (n) is 0.5 and tan δ is 1 [13]. We calculated the 
value of n for our gels by applying a default model to calculate n based on the plot in Data 
Analysis software. It was found to be closer to 1 for all the gel formulations that we used. So 
clearly, the G' and G'' crossover was not the best method to characterize GP for our gels. 
Moreover, as seen in Figure 6  the Gelling time observed was on the order of a few seconds 
which perhaps is too quick for a surgical procedure to take place. However when we repeat the 
tests using multi-frequency tests, the GP values measured are practically more relevant and 
useful. 
 From  
Table 6 we see that the gel time ranges between 600-900 seconds for all the gel formulations 
(except for pure fibrin gels) which is long enough for a surgical procedure to be completed but at 
the same time it is quick enough not to cause the gel to squeeze out of the defect. However, it is 
interesting to observe that addition of genipin to pure fibrin gels slows down the gelling process. 
It is interesting because a previous study on genipin crosslinked chitosan gels indicated that 
genipin actually speeds up the gelling process [11] which is not true when genipin is used to 
crosslink fibrin gels. It could be hypothesized that addition of genipin triggers some sort of 
mechanism which doesn’t allow thrombin to crosslink fibrin as quickly as it does in a pure fibrin 
gel. While 0.5:1 genipin to fibrin ratios had shorter gel times than the 0.25:1 ratio, this concept 
may still hold in a non-linear manner. However, stiffness and degradation was always improved 
with the addition of genipin suggest there was sufficient mechanical integrity and that these 
59 
 
formulations were acceptable. Gel time was highly dependent on temperature. Higher 
temperature caused the gel to form cross-links more quickly compared to lower temperatures at 
which interaction between the materials was slowed and at 4°C there was little evidence of 
gelation. It is not possible to have a precise value for the gelling time because each time the test 
was conducted, some variance resulted from a variety of factors: measurement techniques like 
mixing of gel solution and variability in fibrin and genipin from biological factors. Hence it is 
always ideal to characterize the gelling time as a range of values instead of a precise value. The 
viscosity measurement confirms that pure fibrin gels crosslink much faster than other 
formulations which crosslink in a time range of 1000-1500 secs with little variation amongst 
different groups. 
Water content was studied in AF in a study that reveals that a healthy disc has an AF with 
70-80% water content which decreases as the disc matures. However if the disc is degenerating, 
the water content in the AF increases with increasing degree of degeneration[19]. The 
degradation studies on our gels show that these gels have a water content of approximately 85-
90% which is much higher than the water content of AF but these gels could still be efficiently 
used as a defect filling material since its water content does not change much over a 21-day 
timepoint. This is useful because the degradation period should be long enough to allow 
extracellular matrix to regenerate and fill the defect. However, fibrin alone had a value of Qw 
approaching infinity and water content approaching 1 at day 7 indicating the specimen had 
completely degraded. This makes us conclude that genipin is important to prolong the 
degradation time. Contraction results show that the amount of contraction in the gel is close to 
10%.However the error in measurement can be upto 4%. Therefore the overall contraction was 
small and not anticipated to present a problem during testing or injection. However for actual 
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clinical procedure i.e injection into IVD defects, it would be advisable to use an extra 5% gel 
volume for injection to account for this small amount of contraction upon setting.  
The present study although successful in characterizing the stiffness, gelling, degradation  
as well as contraction properties of the gel, some studies particularly the stiffness results had 
high variance which might need some further testing after fixing the source of variance to get 
better results. It may be considered to test the gel formulations again for stiffness by using 
syringe mixing as a method of gel mixing in future. Variance resulting from biological materials 
such as fibrin and genipin cannot be controlled. Also mixing of high viscous materials adds an 
additional source of variance. The relatively quick gel time (Ranging from 600 to 900sec for 
different gel formulations) makes it possible to use it to fill defects with injection techniques. 
Since the results indicate that the gel does not degrade much over a course of 21 days it might be 
useful to test them on a longer time scale to see if they degrade when kept longer. 
From the results of stiffness studies, GP studies as well as degradation tests, it is seen that 
gels without genipin had poor mechanical properties, very short gel time (around 200 sec) which 
would cause it to gel up even before the gel could be injected properly and it also degraded 
completely by day7. These results indicate that addition of genipin highly improves its 
mechanical properties as well as delays the gel time and degradation period to a desired time. 
However a very significant difference was not observed between all the currently tested 
formulations for the performed studies which suggest that all the formulations have acceptable 
gel time and degradation properties except pure fibrin gels. In case of actual surgical procedure, 
taking into account the time range of 1000-1500 secs obtained for viscosity measurement of 
different formulations, a time of 1500 secs (25 mins) could be defined as safe to resume patient 
mobility. This time frame is good since it would be enough for a surgical procedure to take place 
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but not too long to restrict the patient for long hours. Therefore the gel time of all formulations 
except for pure fibrin gels is adequate. From the results of contraction studies it is seen that there 
is a small amount of contraction in the gels upon setting. To account for that, an additional 5% 
gel volume would be recommended for injection into the defect. The present study does not give 
a clear idea about what gel formulation would work best for in vitro use. Fatigue tests, adhesion 
tests as well as cell viability tests would help in understanding the different gel formulations 
better. Some tests to characterize tensile properties could also be considered in future. 
7.0 CONCLUSION 
Through this study we have systematically studied the rheological properties of genipin 
cross-linked fibrin gels. It was an interesting finding that in case of fibrin crosslinked gels, 
addition of genipin actually slows down the gelling process while in most cases initiators like 
genipin can quicken gelation times. Rheology measurements on these gels allowed us to assess 
its viscoelastic properties and it was learned that the stiffness of the gel is controlled by fibrin 
concentration and genipin:fibrin ratio. Although the present study is useful in characterizing 
many important properties of these gels, it cannot by itself be used to predict which gel 
formulation would work best for clinical purposes. In vivo biocompatibility and in situ 
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